Lisa M Kaminskas

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Idiopathic Pulmonary Fibrosis

Recombinant Human

Heat Shock Protein

Top Venues

Molecular pharmaceutics

Biomaterials science

Biomacromolecules

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Gayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T Blanchfield, Christopher N Subasic, James L Grace, Changkui Fu, Xiao Tan, John F Quinn, David B Ascher, Michael Raymond Whittaker, Andrew Keith Whittaker, Lisa M Kaminskas
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity. Biomaterials science 12 (11) (2024)
Gayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T Blanchfield, Christopher N Subasic, James L Grace, Changkui Fu, Xiao Tan, John F Quinn, David B Ascher, Michael Raymond Whittaker, Andrew Keith Whittaker, Lisa M Kaminskas
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity. Biomaterials science 12 (11) (2024)
Gayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T Blanchfield, Christopher N Subasic, James L Grace, Changkui Fu, Xiao Tan, John F Quinn, David B Ascher, Michael Raymond Whittaker, Andrew Keith Whittaker, Lisa M Kaminskas
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity. Biomaterials science (2024)
Christopher N Subasic, Neville J Butcher, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas
Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats. Molecular pharmaceutics (2023)
Christopher N Subasic, Neville J Butcher, Rodney F Minchin, Lisa M Kaminskas
Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats. Molecular pharmaceutics (2023)
Daniel Hs Brundel, Orlagh M Feeney, Cameron J Nowell, Estelle J A Suys, Gracia Gracia, Lisa M Kaminskas, Michelle M McIntosh, David W Kang, Christopher J H Porter
Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration. Nanomedicine (London, England) 16 (4) (2021)
Nam V Dao, Francesca Ercole, Lisa M Kaminskas, Thomas P Davis, Erica K Sloan, Michael Raymond Whittaker, John F Quinn
Trisulfide-Bearing PEG Brush Polymers Donate Hydrogen Sulfide and Ameliorate Cellular Oxidative Stress. Biomacromolecules 21 (12) (2020)
Esther Kuilamu, Christopher Subasic, Gary J Cowin, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas
Cetuximab Exhibits Sex Differences in Lymphatic Exposure after Intravenous Administration in Rats in the Absence of Differences in Plasma Exposure. Pharmaceutical research 37 (11) (2020)
Lisa M Kaminskas, Cornelia B Landersdorfer, Robert J Bischof, Nathania Leong, Jibriil Ibrahim, Andrew N Davies, Stephen Pham, Steven Beck, A Bruce Montgomery, Mark W Surber
Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis. Pharmaceutical research 37 (1) (2019)
Dharmini Mehta, Nathania Leong, Victoria M McLeod, Brian D Kelly, Rashmi Pathak, David J Owen, Christopher J H Porter, Lisa M Kaminskas
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker. Molecular pharmaceutics 15 (10) (2018)
Linda J Chan, Orlagh M Feeney, Nathania J Leong, Victoria M McLeod, Christopher J H Porter, Charlotte C Williams, Lisa M Kaminskas
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules 18 (9) (2017)